HIV-1 Tat-mediated microglial ferroptosis involves the miR-204-ACSL4 signaling axis

Muthukumar Kannan1, Susmita Sil1, Abiola Oladapo1

  • 1Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198-5880, USA.

Redox Biology
|April 6, 2023
PubMed

Insights

HIV-1 Tat protein triggers microglial ferroptosis via the miR-204-ACSL4 pathway, leading to inflammation. Inhibiting ferroptosis or ACSL4 reduces these effects, suggesting therapeutic targets for HIV-associated neuroinflammation.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglial activation and ferroptosis are implicated in HIV-1 pathogenesis.
  • The HIV-1 Tat protein is a key viral factor influencing neuronal and glial cell function.
  • Understanding mechanisms of microglial ferroptosis is crucial for addressing HIV-associated neuroinflammation.

Purpose of the Study:

  • To investigate the role of HIV-1 Tat protein in inducing microglial ferroptosis.
  • To elucidate the molecular pathways, including miR-204 and ACSL4, involved in Tat-mediated ferroptosis.
  • To explore the link between microglial ferroptosis, inflammation, and HIV-1 infection.

Main Methods:

  • Primary mouse microglial cells (mPMs) were exposed to HIV-1 Tat protein.
  • Ferroptosis was assessed by measuring lipid peroxidation, iron levels, and specific protein markers (ACSL4, FTH1, GPX4).
  • Gene silencing (ACSL4 knockdown) and miRNA mimics (miR-204) were used, along with ferroptosis inhibitors (Fer-1, DFO).
  • Proinflammatory cytokine release (TNFα, IL6, IL1β) and microglial activation were measured.
  • In vivo studies utilized HIV-1 transgenic rats and human brain samples.

Main Results:

  • HIV-1 Tat induced ferroptosis in mPMs, characterized by increased ACSL4, lipid peroxidation, iron, and FTH1, and decreased GPX4.
  • Inhibition of ferroptosis (Fer-1, DFO) or ACSL4 suppressed Tat-induced ferroptosis and microglial activation.
  • HIV-1 Tat downregulated miR-204, which acts upstream of ACSL4.
  • miR-204 mimics reduced ACSL4 expression, inhibited ferroptosis, and decreased cytokine release.
  • Findings were validated in HIV-1 transgenic rats and human brain samples.

Conclusions:

  • HIV-1 Tat protein directly induces microglial ferroptosis through the miR-204-ACSL4 signaling pathway.
  • This ferroptosis contributes to microglial activation and the release of proinflammatory cytokines.
  • Targeting the miR-204-ACSL4 axis may offer a therapeutic strategy for HIV-associated neuroinflammation.

Related Concept Videos